BlackRock Fund Advisors’s Sage Therapeutics SAGE Stock Holding History

BlackRock Fund Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$72.5M	Buy	1,420,226 +231,133	+19%	+$10.9M	0.01%	1431
2016 Q3	$54.8M	Buy	1,189,093 +151,165	+15%	+$6.15M	0.01%	1508
2016 Q2	$31.3M	Buy	1,037,928 +250,382	+32%	+$8.35M	0.01%	1783
2016 Q1	$25.2M	Buy	787,546 +115,027	+17%	+$4.05M	0.01%	1849
2015 Q4	$39.2M	Sell	672,519 -65,915	-9%	-$3.27M	0.01%	1647
2015 Q3	$31.3M	Buy	738,434 +43,963	+6%	+$2.71M	0.01%	1729
2015 Q2	$50.7M	Buy	694,471 +212,931	+44%	+$13.7M	0.01%	1517
2015 Q1	$24.2M	Buy	481,540 +19,592	+4%	+$842K	0.01%	1966
2014 Q4	$16.9M	Buy	461,948 +320,341	+226%	+$11.9M	﹤0.01%	2161
2014 Q3	$4.46M	Buy	+141,607	New	+$4.1M	﹤0.01%	2821

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock Fund Advisors's SAGE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Sage Therapeutics (SAGE) stake by 19% in Q4 2016, buying an estimated $10.9M and bringing the position to 1,420,226 shares worth $72.5M. The position accounts for 0.01% of the portfolio, ranked #1431.

BlackRock Fund Advisors first reported a position in SAGE in Q3 2014 and has held it in 10 quarters since. 166 funds tracked by Wall St. Rank hold SAGE as of Q4 2016.

BlackRock Fund Advisors held 1,420,226 shares of Sage Therapeutics worth $72.5M as of Q4 2016.
BlackRock Fund Advisors bought 231,133 Sage Therapeutics shares in Q4 2016, an estimated $10.9M.
Sage Therapeutics made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1431 holding.
BlackRock Fund Advisors first reported a position in Sage Therapeutics in Q3 2014 and has held it in 10 quarters since.
166 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.